Retrospective Analysis of the Outcome of Patients With Relapsed/Refractory Acute Myeloid Leukemia Included in a Patient Named Program of Gemtuzumab Ozogamicin/Mylotarg®
Clinical trial NCT03287128 · UNKNOWN
Trial details
- NCT number
- NCT03287128
- Sponsor
- Versailles Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-01
- Primary completion
- 2018-10-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.